Felix Kim, PhD

Dr. Felix Kim is the Co-founder, Chief Scientific Officer, and Chair of Scientific Advisory Board of Context Therapeutics. In addition, Felix is currently an Assistant Professor in the Department of Pharmacology & Physiology at Drexel University College of Medicine and is Secretary/Treasurer of the Translational and Clinical Pharmacology division of the American Society for Pharmacology and Experimental Therapeutics (ASPET). Prior to receiving his faculty position at Drexel, Felix completed a Post-Doctoral Fellowship with Dr. Gavril Pasternak at the Memorial Sloan Kettering Cancer Center. Felix is a leading authority on Sigma1 biology, having authored some of the seminal works in the field. He holds a Ph.D. in Biochemistry from Universitè Montepellier (France) and a B.S. in Biology from University of California San Diego.